Fulcrum Therapeutics, Inc.
NasdaqGM:FULC
$ 7.33
+ $0.20 (2.81%)
$ 7.33
+ $0.20 (2.81%)
End-of-day quote: 05/01/2024

FULC - Fulcrum Therapeutics Stock Prediction 2025 - 2030

5 years of reliable Fulcrum Therapeutics stock forecast. The Wall Street analysts predict Outperform for FULC. See at a glance whether NasdaqGM:FULC will rise in the future.

$0.00
Forecast 2023
$8.75
Forecast 2025
$14.88
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$8.75
Forecast 2030
$14.88
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
2.28
Price-to-book Ratio
1.93
Market Cap
0.44B
TEV
0.46 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$10.21

Fulcrum Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Fulcrum Therapeutics Stock Forecast 2023

$14.50

In the last five quarters, Fulcrum Therapeutics’s Price Target has fallen from $22.79 to $10.21 - a -55.2% decrease. Seven analysts predict that Fulcrum Therapeutics’s share price will increase in the coming year, reaching $14.50. This would represent an increase of 42.02%.

97.82%
97.82
Last update: 05/02/2024

Highest Price Target $19.00

Average Price Target $14.50

Lowest Price Target $5.00

Fulcrum Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of $7.95. An increase of 8.42% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of $8.02. An increase of 9.42% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of $8.09. An increase of 10.42% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of $8.17. An increase of 11.42% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of $8.24. An increase of 12.42% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of $8.31. An increase of 13.43% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of $8.39. An increase of 14.43% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of $8.46. An increase of 15.43% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of $8.53. An increase of 16.43% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of $8.61. An increase of 17.43% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of $8.68. An increase of 18.43% compared to today's share price.

Stock Prediction for the Price of One Fulcrum Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of $8.75. An increase of 19.44% compared to today's share price.

Fulcrum Therapeutics Stock Predictions 2030

Fulcrum Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $13.51. An increase of 84.26% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $13.63. An increase of 85.96% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $13.76. An increase of 87.66% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $13.88. An increase of 89.37% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $14.01. An increase of 91.07% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $14.13. An increase of 92.77% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $14.25. An increase of 94.47% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $14.38. An increase of 96.18% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $14.50. An increase of 97.88% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $14.63. An increase of 99.58% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $14.75. An increase of 101.28% compared to the previous month's estimate.

Fulcrum Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $14.88. An increase of 102.98% compared to the previous month's estimate.

P/E
0.00
Beta
2.28
Price-to-book Ratio
1.93
Market Cap
0.44B
TEV
0.46 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$10.21

Fulcrum Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Fulcrum Therapeutics, Inc.?

The following analysts have recently covered Fulcrum Therapeutics:

BofA Global Research
Goldman Sachs
H.C. Wainwright & Co.
Leerink Partners LLC
Oppenheimer & Co. Inc.
Piper Sandler Companies
Stifel
Marktfeld
RBC Capital Markets
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Fulcrum Therapeutics, Inc.?

The following sell-side analysts have recently covered Fulcrum Therapeutics:

Ahmad, Tazeen
Jenkins, Corinne
Fein, Andrew S.
Schwartz, Joseph Patrick
Biegler, Matthew Cornell
Tenthoff, Edward Andrew
Ha, Dae Gon
Paraskevopoulos, Michail
Renza, Gregory James
(This information refers to the last 90 days.)